SCHEMBL2729508

SCHEMBL2729508

CCCCCCCCCC=C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.54
TSHR P16473 3/20 0.48
THRB P10828 1/20 0.44
FAAH O00519 3/20 0.42
TRPV1 Q8NER1 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
TERT O14746 3/20 0.41
MAPT P10636 2/20 0.41
BLM P54132 2/20 0.41
HSD17B10 Q99714 2/20 0.41
FABP4 P15090 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613199 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613312 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613189 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613340 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL72975 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613352 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL83372 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL1416712 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL5613296 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1
SCHEMBL28120005 1.00 EP300 (0.54) EP300TSHRTHRBFAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587496-A1 CURABLE SILICONE COMPOSITIONS CONTAINING ADDITIVES Henkel AG & Co. KGaA (DE) 2025-07-23 EP disclosed
WO-2024056507-A1 CURABLE SILICONE COMPOSITIONS CONTAINING ADDITIVES HENKEL AG & CO. KGAA (DE) 2024-03-21 WO disclosed
CN-111807941-B Method for synthesizing alpha-diketone compound by catalyzing with metal salt 武汉理工大学 2022-07-05 CN disclosed
US-10328688-B2 Tunable surfactants in dampening fluids for digital offset ink printing applications XEROX CORPORATION (US) 2019-06-25 US disclosed
EP-2678410-B1 COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES PROCTER & GAMBLE (US) 2017-09-13 EP disclosed
US-20170225452-A1 TUNABLE SURFACTANTS IN DAMPENING FLUIDS FOR DIGITAL OFFSET INK PRINTING APPLICATIONS Genesee Valley Innovations, LLC 2017-08-10 US disclosed
US-9713828-B2 Tunable surfactants in dampening fluids for digital offset ink printing applications XEROX CORPORATION (US) 2017-07-25 US disclosed
US-9193937-B2 Mixtures of C10-C13 alkylphenyl sulfonates THE PROCTER & GAMBLE COMPANY (US) 2015-11-24 US disclosed
US-20150040939-A1 TUNABLE SURFACTANTS IN DAMPENING FLUIDS FOR DIGITAL OFFSET INK PRINTING APPLICATIONS Genesee Valley Innovations, LLC 2015-02-12 US disclosed
EP-2632498-A1 MALODOR CONTROL COMPOSITIONS Nestec S.A. (CH) 2013-09-04 EP disclosed
US-20130087167-A1 TUNABLE SURFACTANTS IN DAMPENING FLUIDS FOR DIGITAL OFFSET INK PRINTING APPLICATIONS XEROX CORPORATION (US) 2013-04-11 US disclosed
WO-2012138423-A1 COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES THE PROCTER & GAMBLE COMPANY (US) 2012-10-11 WO disclosed
US-20120214724-A1 Mixtures OF C10-C13 Alkylphenyl Sulfonates THE PROCTER & GAMBLE COMPANY 2012-08-23 US disclosed
WO-2012057825-A1 MALODOR CONTROL COMPOSITIONS NESTEC S.A. (CH) 2012-05-03 WO disclosed
US-20070270521-A1 Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
CN-101024659-A Transition metal compound, polymerization initiator system including same and polymer production method SUMITOMO CHEMICAL CO (JP) 2007-08-29 CN disclosed
WO-2000069921-A1 AMINE-FUNCTIONALISED COPOLYMERS AND METHODS FOR THEIR PREPARATION BP CHEMICALS LIMITED (GB) 2000-11-23 WO disclosed
US-5864051-A OXIDATION CATALYST CONTAINING NOBLE METAL ALLOYED ANTIMONY OXIDE, OPTIONALLY MODIFER AND/OR A REFRACTORY INORGANIC OXIDES; USEFUL FOR SELECTIVE OXIDATION OF ALKANES OR ALKENES TO CORRESPONDING ALDEHYDE OR KETONES UOP (US) 1999-01-26 US disclosed
EP-0748823-A1 Catalyst composition and process for the production of olefinic polymers NIPPON OIL CO. LTD. (JP) 1996-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270521-A1 Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer CARM1, CPN1, CCNT1 EP300 1453/4885TSHR 4291/4885THRB 3489/4885
US-20120214724-A1 Mixtures OF C10-C13 Alkylphenyl Sulfonates SMURF1, C1S, SMURF2 EP300 121/4885TSHR 2411/4885THRB 4781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.